Akt: A double-edged sword in cell proliferation and genome stability

Journal of Oncology

Volumn , Issue , 2012, Pages

  Xu, Naihan ^a   Lao, Yuanzhi ^b   Zhang, Yaou ^a   Gillespie, David A ^c,d  

^a TSINGHUA UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; CHECKPOINT KINASE 1; DOXORUBICIN; ETOPOSIDE; GSK 2110183; GSK 2141795; MAMMALIAN TARGET OF RAPAMYCIN; MK 2206; MRE11 PROTEIN; MYC PROTEIN; NIBRIN; PERIFOSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN AKT 1; PROTEIN AKT 3; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN KINASE C; PROTEIN S3; RAD51 PROTEIN; RIBOSOME PROTEIN; RX 0201; TEMOZOLOMIDE; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADVANCED CANCER; ALVEOLAR SOFT PART SARCOMA; BILE DUCT CANCER; BRAIN CANCER; BRAIN DEVELOPMENT; BRAIN TUMOR; BREAST CANCER; CANCER PATIENT; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CHONDROSARCOMA; COLON CANCER; COLORECTAL CANCER; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; GLIOBLASTOMA; GLIOMA; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HISTIOCYTOSIS X; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LEUKEMIA; LIVER CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; MELANOMA; MULTIPLE MYELOMA; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; NONHUMAN; ONCOGENESIS AND MALIGNANT TRANSFORMATION; OVARY CANCER; PANCREAS CANCER; PERITONEUM CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; RECOMBINATION REPAIR; REVIEW; SIGNAL TRANSDUCTION; SMALL INTESTINE CANCER; SOLID TUMOR; STOMACH CANCER; TUMOR CELL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 84859739738     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/951724     Document Type: Review

References (191)

1. Jones P. F., Jakubowicz T., Hemmings B. A., Molecular cloning of a second form of rac protein kinase Cell Regulation 1991 2 12 1001 1009
2. Cheng J. Q., Godwin A. K., Bellacosa A., Taguchi T., Franke T. F., Hamilton T. C., Tsichlis P. N., Testa J. R., AKT2, a putative oncogene encoding a member of a subfamily of protein- serine/threonine kinases, is amplified in human ovarian carcinomas Proceedings of the National Academy of Sciences of the United States of America 1992 89 19 9267 9271
3. Brodbeck D., Cron P., Hemmings B. A., A human protein kinase B with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain Journal of Biological Chemistry 1999 274 14 9133 9136
4. Vanhaesebroeck B., Alessi D. R., The PI3K-PBK1 connection: more than just a road to PKB Biochemical Journal 2000 346 3 561 576 (Pubitemid 30171014)
5. Coffer P. J., Woodgett J. R., Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families European Journal of Biochemistry 1991 201 2 475 481
6. Altomare D. A., Guo K., Cheng J. Q., Sonoda G., Walsh K., Testa J. R., Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene Oncogene 1995 11 6 1055 1060
7. Altomare D. A., Lyons G. E., Mitsuuchi Y., Cheng J. Q., Testa J. R., Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin Oncogene 1998 16 18 2407 2411 (Pubitemid 28226889)
8. Chen W. S., Xu P. Z., Gottlob K., Chen M. L., Sokol K., Shiyanova T., Roninson I., Weng W., Suzuki R., Tobe K., Kadowaki T., Hay N., Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene Genes and Development 2001 15 17 2203 2208 (Pubitemid 32843832)
9. Cho H., Thorvaldsen J. L., Chu Q., Feng F., Birnbaum M. J., Akt1/PKB Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice Journal of Biological Chemistry 2001 276 42 38349 38352
10. Garofalo R. S., Orena S. J., Rafidi K., Torchia A. J., Stock J. L., Hildebrandt A. L., Coskran T., Black S. C., Brees D. J., Wicks J. R., McNeish J. D., Coleman K. G., Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB Journal of Clinical Investigation 2003 112 2 197 208 (Pubitemid 38056356)
11. Cho H., Mu J., Kim J. K., Thorvaldsen J. L., Chu Q., Crenshaw E. B., Kaestner K. H., Bartolomei M. S., Shulman G. I., Birnbaum M. J., Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB ) Science 2001 292 5522 1728 1731 (Pubitemid 32506248)
12. Yang Z. Z., Tschopp O., Baudry A., Dmmler B., Hynx D., Hemmings B. A., Physiological functions of protein kinase B/Akt Biochemical Society Transactions 2004 32 2 350 354 (Pubitemid 38582126)
13. Song G., Ouyang G., Bao S., The activation of Akt/PKB signaling pathway and cell survival Journal of Cellular and Molecular Medicine 2005 9 1 59 71
14. Ferguson K. M., Kavran J. M., Sankaran V. G., Fournier E., Isakoff S. J., Skolnik E. Y., Lemmon M. A., Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains Molecular Cell 2000 6 2 373 384
15. Franke T. F., Kaplan D. R., Cantley L. C., Toker A., Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate Science 1997 275 5300 665 668 (Pubitemid 27061333)
16. Stokoe D., Stephens L. R., Copeland T., Gaffney P. R. J., Reese C. B., Painter G. F., Holmes A. B., McCormick F., Hawkins P. T., Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B Science 1997 277 5325 567 570 (Pubitemid 27369005)
17. Lietzke S. E., Bose S., Cronin T., Klarlund J., Chawla A., Czech M. P., Lambright D. G., Structural basis of 3-phosphoinositide recognition by Pleckstrin homology domains Molecular Cell 2000 6 2 385 394
18. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A., Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO Journal 1996 15 23 6541 6551 (Pubitemid 26413787)
19. Sarbassov D. D., Guertin D. A., Ali S. M., Sabatini D. M., Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 2005 307 5712 1098 1101 (Pubitemid 40262113)
20. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S., Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase Proceedings of the National Academy of Sciences of the United States of America 1998 95 19 11211 11216 (Pubitemid 28450107)
21. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C. P., Alessi D. R., PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2 Current Biology 1999 9 8 393 404 (Pubitemid 29205782)
22. Sable C. L., Filippa N., Hemmings B., Van Obberghen E., cAMP stimulates protein kinase B in a Wortmannin-insensitive manner FEBS Letters 1997 409 2 253 257 (Pubitemid 27273887)
23. Filippa N., Sable C. L., Filloux C., Hemmings B., Van Obberghen E., Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase Molecular and Cellular Biology 1999 19 7 4989 5000 (Pubitemid 29289538)
24. Yano S., Tokumitsu H., Soderling T. R., Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway Nature 1998 396 6711 584 587 (Pubitemid 28563720)
25. Pérez-Garca M. J., Cea V., De Pablo Y., Llovera M., Comella J. X., Soler R. M., Glial cell line-derived neurotrophic factor increases intracellular calcium concentration: role of calcium/calmodulin in the activation of the phosphatidylinositol 3-kinase pathway Journal of Biological Chemistry 2004 279 7 6132 6142 (Pubitemid 38220646)
26. Myers M. P., Tonks N. K., PTEN: sometimes taking it off can be better than putting it on American Journal of Human Genetics 1997 61 6 1234 1238 (Pubitemid 28046897)
27. Cantley L. C., Neel B. G., New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proceedings of the National Academy of Sciences of the United States of America 1999 96 8 4240 4245 (Pubitemid 29190320)
28. Osaki M., Oshimura M., Ito H., PI3K-Akt pathway: its functions and alterations in human cancer Apoptosis 2004 9 6 667 676 (Pubitemid 40941196)
29. Leslie N. R., Downes C. P., PTEN function: how normal cells control it and tumour cells lose it Biochemical Journal 2004 382 1 1 11 (Pubitemid 39141560)
30. Sansal I., Sellers W. R., The biology and clinical relevance of the PTEN tumor suppressor pathway Journal of Clinical Oncology 2004 22 14 2954 2963 (Pubitemid 41079915)
31. Sulis M. L., Parsons R., PTEN: from pathology to biology Trends in Cell Biology 2003 13 9 478 483 (Pubitemid 37289398)
32. Maehama T., Dixon J. E., The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate Journal of Biological Chemistry 1998 273 22 13375 13378 (Pubitemid 28268370)
33. Brognard J., Newton A. C., PHLiPPing the switch on Akt and protein kinase C signaling Trends in Endocrinology and Metabolism 2008 19 6 223 230 (Pubitemid 351993013)
34. Gao T., Furnari F., Newton A. C., PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth Molecular Cell 2005 18 1 13 24 (Pubitemid 40444644)
35. Brognard J., Sierecki E., Gao T., Newton A. C., PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms Molecular Cell 2007 25 6 917 931 (Pubitemid 46436532)
36. Liu J., Weiss H. L., Rychahou P., Jackson L. N., Evers B. M., Gao T., Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis Oncogene 2009 28 7 994 1004
37. Chen M., Pratt C., Zeeman M., Schultz N., Taylor B., O'Neill A., Castillo-Martin M., Nowak D., Naguib A., Grace D., Murn J., Navin N., Atwal G., Sander C., Gerald W., Cordon-Cardo C., Newton A., Carver B., Trotman L., Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression Cancer Cell 2011 20 2 173 186
38. Qiao M., Iglehart J. D., Pardee A. B., Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation Cancer Research 2007 67 11 5293 5299 (Pubitemid 46997268)
39. Fingar D. C., Salama S., Tsou C., Harlow E., Blenis J., Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes and Development 2002 16 12 1472 1487 (Pubitemid 34686329)
40. Sarbassov D. D., Ali S. M., Sabatini D. M., Growing roles for the mTOR pathway Current Opinion in Cell Biology 2005 17 6 596 603 (Pubitemid 41540408)
41. Saucedo L. J., Edgar B. A., Why size matters: altering cell size Current Opinion in Genetics and Development 2002 12 5 565 571 (Pubitemid 35013539)
42. Tapon N., Moberg K. H., Hariharan I. K., The coupling of cell growth to the cell cycle Current Opinion in Cell Biology 2001 13 6 731 737 (Pubitemid 33042734)
43. Gartel A. L., Shchors K., Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes Experimental Cell Research 2003 283 1 17 21 (Pubitemid 36259892)
44. Ahmed N. N., Grimes H. L., Bellacosa A., Chan T. O., Tsichlis P. N., Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase Proceedings of the National Academy of Sciences of the United States of America 1997 94 8 3627 3632 (Pubitemid 27180423)
45. Sears R., Nuckolls F., Haura E., Taya Y., Tamai K., Nevins J. R., Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability Genes and Development 2000 14 19 2501 2514
46. Pelengaris S., Khan M., Evan G., c-MYC: more than just a matter of life and death Nature Reviews Cancer 2002 2 10 764 776 (Pubitemid 37328911)
47. Diehl J. A., Cheng M., Roussel M. F., Sherr C. J., Glycogen synthase kinase-3 regulates cyclin D1 proteolysis and subcellular localization Genes and Development 1998 12 22 3499 3511 (Pubitemid 28553242)
48. Alt J. R., Cleveland J. L., Hannink M., Diehl J. A., Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation Genes and Development 2000 14 24 3102 3114 (Pubitemid 32015129)
49. Brennan P., Babbage J. W., Burgering B. M. T., Groner B., Reif K., Cantrell D. A., Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F Immunity 1997 7 5 679 689 (Pubitemid 28156635)
50. Zhou B. P., Liao Y., Xia W., Spohn B., Lee M. H., Hung M. C., Cytoplasmic localization of p21 CIP1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells Nature Cell Biology 2001 3 3 245 252 (Pubitemid 32201319)
51. Rssig L., Jadidi A. S., Urbich C., Badorff C., Zeiher A. M., Dimmeler S., Akt-dependent phosphorylation of p21Cip1 regulates PCNA binding and proliferation of endothelial cells Molecular and Cellular Biology 2001 21 16 5644 5657 (Pubitemid 32702467)
52. Li Y., Dowbenko D., Lasky L. A., AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival Journal of Biological Chemistry 2002 277 13 11352 11361 (Pubitemid 34952901)
53. Jung J. M., Bruner J. M., Ruan S., Langford L. A., Kyritsis A. P., Kobayashi T., Levin V. A., Zhang W., Increased levels of p21(WAF1)/(Cip1) in human brain tumors Oncogene 1995 11 10 2021 2028 (Pubitemid 3000314)
54. Medema R. H., Kops G. J. P. L., Bos J. L., Burgering B. M. T., AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27(kip1) Nature 2000 404 6779 782 787 (Pubitemid 30212408)
55. Viglietto G., Motti M. L., Bruni P., Melillo R. M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichliss P., Bellacosa A., Fusco A., Santoro M., Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27kip1 by PKB/Akt-mediated phosphorylation in breast cancer Nature Medicine 2002 8 10 1136 1144 (Pubitemid 35175969)
56. Shin I., Yakes F. M., Rojo F., Shin N. Y., Bakin A. V., Baselga J., Arteaga C. L., PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization Nature Medicine 2002 8 10 1145 1152 (Pubitemid 35175970)
57. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M. K., Han K., Lee J. H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., Slingerland J. M., PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nature Medicine 2002 8 10 1153 1160 (Pubitemid 35175971)
58. Fujita N., Sato S., Katayama K., Tsuruo T., Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization Journal of Biological Chemistry 2002 277 32 28706 28713
59. Rodier G., Montagnoli A., Di Marcotullio L., Coulombe P., Draetta G. F., Pagano M., Meloche S., p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis EMBO Journal 2001 20 23 6672 6682 (Pubitemid 33134197)
60. Sekimoto T., Fukumoto M., Yoneda Y., 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27Kip1 EMBO Journal 2004 23 9 1934 1942 (Pubitemid 38902071)
61. Ciaparrone M., Yamamoto H., Yao Y., Sgambato A., Cattoretti G., Tomita N., Monden T., Rotterdam H., Weinstein I. B., Localization and expression of p27(KIP1) in multistage colorectal carcinogenesis Cancer Research 1998 58 1 114 122 (Pubitemid 28027726)
62. Singh S. P., Lipman J., Goldman H., Ellis F. H., Aizenman L., Cangi M. G., Signoretti S., Chiaur D. S., Pagano M., Loda M., Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma Cancer Research 1998 58 8 1730 1735 (Pubitemid 28215101)
63. Lin H. K., Wang G., Chen Z., Teruya-Feldstein J., Liu Y., Chan C. H., Yang W. L., Erdjument-Bromage H., Nakayama K. I., Nimer S., Tempst P., Pandolfi P. P., Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB Nature Cell Biology 2009 11 4 420 432
64. Gao D., Inuzuka H., Tseng A., Chin R. Y., Toker A., Wei W., Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction Nature Cell Biology 2009 11 4 397 408
65. Carrano A. C., Eytan E., Hershko A., Pagano M., SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nature Cell Biology 1999 1 4 193 199 (Pubitemid 129500937)
66. Sutterlty H., Chatelain E., Marti A., Wirbelauer C., Senften M., Mller U., Krek W., p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells Nature Cell Biology 1999 1 4 207 214 (Pubitemid 129500939)
67. Ganoth D., Bornstein G., Ko T. K., Larsen B., Tyers M., Pagano M., Hershko A., The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27 Nature Cell Biology 2001 3 3 321 324 (Pubitemid 32201330)
68. Spruck C., Strohmaier H., Watson M., Smith A. P. L., Ryan A., Krek W., Reed S. I., A CDK-independent function of mammalian Cks1: targeting of SCFSkp2 to the CDK inhibitor p27Kip1 Molecular Cell 2001 7 3 639 650 (Pubitemid 32706355)
69. Levine A. J., p53, the cellular gatekeeper for growth and division Cell 1997 88 3 323 331 (Pubitemid 27131374)
70. Bates S., Vousden K. H., Mechanisms of p53-mediated apoptosis Cellular and Molecular Life Sciences 1999 55 1 28 37 (Pubitemid 29077852)
71. Kubbutat M. H. G., Jones S. N., Vousden K. H., Regulation of p53 stability by Mdm2 Nature 1997 387 6630 299 303 (Pubitemid 27220767)
72. Haupt Y., Maya R., Kazaz A., Oren M., Mdm2 promotes the rapid degradation of p53 Nature 1997 387 6630 296 299 (Pubitemid 27220766)
73. Ashcroft M., Ludwig R. L., Woods D. B., Copeland T. D., Weber H. O., MacRae E. J., Vousden K. H., Phosphorylation of HDM2 by Akt Oncogene 2002 21 13 1955 1962 (Pubitemid 34270884)
74. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., Gotoh Y., Akt enhances Mdm2-mediated ubiquitination and degradation of p53 Journal of Biological Chemistry 2002 277 24 21843 21850 (Pubitemid 34952337)
75. Mayo L. D., Donner D. B., A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11598 11603 (Pubitemid 32928774)
76. Kawai H., Lopez-Pajares V., Kim M. M., Wiederschain D., Yuan Z. M., RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity Cancer Research 2007 67 13 6026 6030 (Pubitemid 47037481)
77. Linares L. K., Hengstermann A., Ciechanover A., Mller S., Scheffner M., HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 12009 12014 (Pubitemid 37271506)
78. Lopez-Pajares V., Kim M. M., Yuan Z. M., Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding Journal of Biological Chemistry 2008 283 20 13707 13713
79. Shtivelman E., Sussman J., Stokoe D., A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle Current Biology 2002 12 11 919 924 (Pubitemid 34689227)
80. Kandel E. S., Skeen J., Majewski N., Di Cristofano A., Pandolfi P. P., Feliciano C. S., Gartel A., Hay N., Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage Molecular and Cellular Biology 2002 22 22 7831 7841 (Pubitemid 35217294)
81. Karlsson C., Katich S., Hagting A., Hoffmann I., Pines J., Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis Journal of Cell Biology 1999 146 3 573 583 (Pubitemid 29388132)
82. Baldin V., Theis-Febvre N., Benne C., Froment C., Cazales M., Burlet-Schiltz O., Ducommun B., PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation Biology of the Cell 2003 95 8 547 554 (Pubitemid 37461485)
83. Nilsson I., Hoffmann I., Cell cycle regulation by the Cdc25 phosphatase family Progress in cell cycle research 2000 4 107 114
84. Davezac N., Baldin V., Gabrielli B., Forrest A., Theis-Febvre N., Yashida M., Ducommun B., Regulation of CDC25B phosphatases subcellular localization Oncogene 2000 19 18 2179 2185 (Pubitemid 30307183)
85. Katayama K., Fujita N., Tsuruo T., Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition Molecular and Cellular Biology 2005 25 13 5725 5737 (Pubitemid 40853605)
86. Okumura E., Fukuhara T., Yoshida H., Hanada S. I., Kozutsumi R., Mori M., Tachibana K., Kishimoto T., Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition Nature Cell Biology 2002 4 2 111 116 (Pubitemid 34141476)
87. Maddika S., Sande S. R., Wiechec E., Hansen L. L., Wesselborg S., Los M., Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis Journal of Cell Science 2008 121 7 979 988 (Pubitemid 351639417)
88. Maddika S., Panigrahi S., Wiechec E., Wesselborg S., Fischer U., Schulze-Osthoff K., Los M., Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity Molecular and Cellular Biology 2009 29 5 1235 1248
89. Brognard J., Clark A. S., Ni Y., Dennis P. A., Akt/pbotein kinace B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Research 2001 61 10 3986 3997 (Pubitemid 32720961)
90. Lu D., Huang J., Basu A., Protein kinase C activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor- -induced cell death Journal of Biological Chemistry 2006 281 32 22799 22807
91. Guinea Viniegra J., Martnez N., Modirassari P., Hernndez Losa J., Parada Cobo C., Snchez-Arévalo Lobo V. J., Aceves Luquero C. I., lvarez-Vallina L., Ramn Y Cajal S., Rojas J. M., Snchez-Prieto R., Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM Journal of Biological Chemistry 2005 280 6 4029 4036 (Pubitemid 40288566)
92. Bozulic L., Surucu B., Hynx D., Hemmings B. A., PKB /Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival Molecular Cell 2008 30 2 203 213 (Pubitemid 351626686)
93. Caporali S., Levati L., Starace G., Ragone G., Bonmassar E., Alvino E., D'Atri S., AKT is activated in an ataxia-telangiectasia and Rad3-related- dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition Molecular Pharmacology 2008 74 1 173 183 (Pubitemid 351872168)
94. Spacey S. D., Gatti R. A., Bebb G., The molecular basis and clinical management of ataxia telangiectasia Canadian Journal of Neurological Sciences 2000 27 3 184 191
95. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J. N., Ried T., Tagle D., Wynshaw-Boris A., Atm-deficient mice: a paradigm of ataxia telangiectasia Cell 1996 86 1 159 171 (Pubitemid 26259926)
96. Boehme K. A., Kulikov R., Blattner C., p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7785 7790 (Pubitemid 351872716)
97. Lees-Miller S. P., PIKK-ing a new partner: a new role for PKB in the DNA damage response Cancer Cell 2008 13 5 379 380 (Pubitemid 351609449)
98. Toker A., Akt signaling: a damaging interaction makes good Trends in Biochemical Sciences 2008 33 8 356 359
99. King F. W., Skeen J., Hay N., Shtivelman E., Inhibition of Chk1 by activated PKB/Akt Cell Cycle 2004 3 5 634 637 (Pubitemid 40278209)
100. Tonic I., Yu W. N., Park Y., Chen C. C., Hay N., Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 foci Journal of Biological Chemistry 2010 285 31 23790 23798
101. Puc J., Keniry M., Li H. S., Pandita T. K., Choudhury A. D., Memeo L., Mansukhani M., Murty V. V. V. S., Gaciong Z., Meek S. E. M., Piwnica-Worms H., Hibshoosh H., Parsons R., Lack of PTEN sequesters CHK1 and initiates genetic instability Cancer Cell 2005 7 2 193 204 (Pubitemid 40248344)
102. Henry M. K., Lynch J. T., Eapen A. K., Quelle F. W., DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway Blood 2001 98 3 834 841
103. Hirose Y., Katayama M., Mirzoeva O. K., Berger M. S., Pieper R. O., Akt activation suppresses Chk2-mediated, methylating agent-induced G 2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence Cancer Research 2005 65 11 4861 4869 (Pubitemid 40740825)
104. Sancar A., Lindsey-Boltz L. A., nsal-Kamaz K., Linn S., Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annual Review of Biochemistry 2004 73 39 85 (Pubitemid 39050363)
105. Helleday T., Lo J., van Gent D. C., Engelward B. P., DNA double-strand break repair: from mechanistic understanding to cancer treatment DNA Repair 2007 6 7 923 935 (Pubitemid 46880473)
106. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., Lopez B. S., Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells Molecular Cell 2004 14 5 611 623 (Pubitemid 38744575)
107. Daley J. M., Palmbos P. L., Wu D., Wilson T. E., Nonhomologous end joining in yeast Annual Review of Genetics 2005 39 431 451 (Pubitemid 43011122)
108. Lieber M. R., Ma Y., Pannicke U., Schwarz K., Mechanism and regulation of human non-homologous DNA end-joining Nature Reviews Molecular Cell Biology 2003 4 9 712 720 (Pubitemid 37082186)
109. Sonoda E., Hochegger H., Saberi A., Taniguchi Y., Takeda S., Differential usage of non-homologous end-joining and homologous recombination in double strand break repair DNA Repair 2006 5 9-10 1021 1029 (Pubitemid 44291617)
110. Wohlbold L., Fisher R. P., Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage DNA Repair 2009 8 9 1018 1024
111. Toulany M., Kasten-Pisula U., Brammer I., Wang S., Chen J., Dittmann K., Baumann M., Dikomey E., Rodemann H. P., Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair Clinical Cancer Research 2006 12 13 4119 4126 (Pubitemid 44078101)
112. Kao G. D., Jiang Z., Fernandes A. M., Gupta A. K., Maity A., Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation Journal of Biological Chemistry 2007 282 29 21206 21212 (Pubitemid 47099899)
113. Toulany M., Kehlbach R., Florczak U., Sak A., Wang S., Chen J., Lobrich M., Rodemann H. P., Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair Molecular Cancer Therapeutics 2008 7 7 1772 1781
114. Toulany M., Kehlbach R., Rodemann H. P., Mozdarani H., Radiocontrast media affect radiation-induced DNA damage repair in vitro and in vivo by affecting Akt signalling Radiotherapy and Oncology 2010 94 1 110 116
115. Golding S. E., Morgan R. N., Adams B. R., Hawkins A. J., Povirk L. F., Valerie K., Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells Cancer Biology and Therapy 2009 8 8 730 738
116. Chen B. P. C., Uematsu N., Kobayashi J., Lerenthal Y., Krempler A., Yajima H., Lbrich M., Shiloh Y., Chen D. J., Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break Journal of Biological Chemistry 2007 282 9 6582 6587 (Pubitemid 47100815)
117. Lavin M. F., Kozlov S., DNA damage-induced signalling in ataxia-telangiectasia and related syndromes Radiotherapy and Oncology 2007 83 3 231 237 (Pubitemid 46907976)
118. Feng J., Park J., Cron P., Hess D., Hemmings B. A., Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase Journal of Biological Chemistry 2004 279 39 41189 41196 (Pubitemid 39287721)
119. Richardson C., Stark J. M., Ommundsen M., Jasin M., Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability Oncogene 2004 23 2 546 553 (Pubitemid 38175009)
120. Bishop A. J. R., Schiestl R. H., Homologous recombination and its role in carcinogenesis Journal of Biomedicine and Biotechnology 2002 2002 2 75 85 (Pubitemid 44204493)
121. Plo I., Laulier C., Gauthier L., Lebrun F., Calvo F., Lopez B. S., AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD5 Cancer Research 2008 68 22 9404 9412
122. Xu N., Hegarat N., Black E. J., Scott M. T., Hochegger H., Gillespie D. A., Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2 Journal of Cell Biology 2010 190 3 297 306
123. Barré B., Perkins N. D., A cell cycle regulatory network controlling NF- B subunit activity and function EMBO Journal 2007 26 23 4841 4855 (Pubitemid 350191299)
124. Pedram A., Razandi M., Evinger A. J., Lee E., Levin E. R., Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair Molecular Biology of the Cell 2009 20 14 3374 3389
125. Lee S. B., Kwon I. S., Park J., Lee K. H., Ahn Y., Lee C., Kim J., Choi S. Y., Cho S. W., Ahn J. Y., Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair Journal of Biological Chemistry 2010 285 38 29457 29468
126. Plo I., Lopez B., AKT1 represses gene conversion induced by different genotoxic stresses and induces supernumerary centrosomes and aneuploidy in hamster ovary cells Oncogene 2009 28 22 2231 2237
127. Walker M., Black E. J., Oehler V., Gillespie D. A., Scott M. T., Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity Oncogene 2009 28 24 2314 2323
128. Zachos G., Rainey M. D., Gillespie D. A. F., Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects EMBO Journal 2003 22 3 713 723 (Pubitemid 36193615)
129. Zachos G., Rainey M. D., Gillespie D. A. F., Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures Molecular and Cellular Biology 2005 25 2 563 574 (Pubitemid 40096579)
130. Smith J., Mun Tho L., Xu N., Gillespie D. A., The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer Advances in Cancer Research 2010 108 C 73 112
131. Garcia V., Furuya K., Carr A. M., Identification and functional analysis of TopBP1 and its homologs DNA Repair 2005 4 11 1227 1239 (Pubitemid 41540442)
132. Kumagai A., Lee J., Yoo H. Y., Dunphy W. G., TopBP1 activates the ATR-ATRIP complex Cell 2006 124 5 943 955 (Pubitemid 43344235)
133. Toledo L. I., Murga M., Gutierrez-Martinez P., Soria R., Fernandez-Capetillo O., ATR signaling can drive cells into senescence in the absence of DNA breaks Genes and Development 2008 22 3 297 302 (Pubitemid 351214271)
134. Liu K., Paik J. C., Wang B., Lin F. T., Lin W. C., Regulation of TopBP1 oligomerization by Akt/PKB for cell survival EMBO Journal 2006 25 20 4795 4807 (Pubitemid 44607025)
135. Altiok S., Batt D., Altiokl N., Papautsky A., Downward J., Roberts T. M., Avrahamt H., Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-kinase/AKT in breast cancer cells Journal of Biological Chemistry 1999 274 45 32274 32278
136. Hinton C. V., Fitzgerald L. D., Thompson M. E., Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1 Experimental Cell Research 2007 313 9 1735 1744 (Pubitemid 46667130)
137. Miralem T., Avraham H. K., Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus Molecular and Cellular Biology 2003 23 2 579 593 (Pubitemid 36050551)
138. Xiang T., Ohashi A., Huang Y., Pandita T. K., Ludwig T., Powell S. N., Yang Q., Negative regulation of AKT activation by BRCA1 Cancer Research 2008 68 24 10040 10044
139. Schfer T., Maco B., Petfalski E., Tollervey D., Bttcher B., Aebi U., Hurt E., Hrr25-dependent phosphorylation state regulates organization of the pre-40S subunit Nature 2006 441 7093 651 655 (Pubitemid 43927298)
140. Grabowski D. T., Deutsch W. A., Derda D., Kelley M. R., Drosophila AP3, a presumptive DNA repair protein, is homologous to human ribosomal associated protein PO Nucleic Acids Research 1991 19 15 4297
141. Kim J., Chubatsu L. S., Admon A., Stahl J., Fellous R., Linn S., Implication of mammalian ribosomal protein S3 in the processing of DNA damage Journal of Biological Chemistry 1995 270 23 13620 13629
142. Kim S. H., Lee J. Y., Kim J., Characterization of a wide range base-damage-endonuclease activity of mammalian rpS3 Biochemical and Biophysical Research Communications 2005 328 4 962 967 (Pubitemid 40238730)
143. Hegde V., Yadavilli S., Deutsch W. A., Knockdown of ribosomal protein S3 protects human cells from genotoxic stress DNA Repair 2007 6 1 94 99 (Pubitemid 46014551)
144. Radyuk S. N., Michalak K., Rebrin I., Sohal R. S., Orr W. C., Effects of ectopic expression of Drosophila DNA glycosylases dOgg1 and RpS3 in mitochondria Free Radical Biology and Medicine 2006 41 5 757 764 (Pubitemid 44177660)
145. Deng R., Tang J., Ma J. G., Chen S. P., Xia L. P., Zhou W. J., Li D. D., Feng G. K., Zeng Y. X., Zhu X. F., PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation Oncogene 2011 30 944 955
146. Tsai M. S., Kuo Y. H., Chiu Y. F., Su Y. C., Lin Y. W., Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells Journal of Pharmacology and Experimental Therapeutics 2010 335 3 830 840
147. Ko J. C., Ciou S. C., Jhan J. Y., Cheng C. M., Su Y. J., Chuang S. M., Lin S. T., Chang C. C., Lin Y. W., Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells Molecular Cancer Research 2009 7 8 1378 1389
148. Hennessy B. T., Smith D. L., Ram P. T., Lu Y., Mills G. B., Exploiting the PI3K/AKT pathway for cancer drug discovery Nature Reviews Drug Discovery 2005 4 12 988 1004
149. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
150. Calvo E., Bols M. V., Grande E., Multiple roles and therapeutic implications of Akt signaling in cancer OncoTargets and Therapy 2009 2 135 150
151. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., Stokoe D., Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC Current Biology 1998 8 21 1195 1198 (Pubitemid 28494720)
152. Roy H. K., Olusola B. F., Clemens D. L., Karolski W. J., Ratashak A., Lynch H. T., Smyrk T. C., AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis Carcinogenesis 2002 23 1 201 205 (Pubitemid 34213570)
153. Ali I. U., Schriml L. M., Dean M., Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity Journal of the National Cancer Institute 1999 91 22 1922 1932
154. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer Nature Reviews Cancer 2002 2 7 489 501 (Pubitemid 37328931)
155. Parsons D. W., Wang T. L., Samuels Y., Bardelli A., Cummins J. M., DeLong L., Silliman N., Ptak J., Szabo S., Willson J. K. V., Markowitz S., Kinzler K. W., Vogelstein B., Lengauer C., Velculescu V. E., Colorectal cancer: mutations in a signalling pathway Nature 2005 436 7052 792 (Pubitemid 41160630)
156. Carnero A., The PKB/AKT pathway in cancer Current Pharmaceutical Design 2010 16 1 34 44
157. Woenckhaus J., Steger K., Werner E., Fenic I., Gamerdinger U., Dreyer T., Stahl U., Genomic gain of PIK3CA and increased expression of pI I 0alpha are associated with progression of dysplasia into invasive squamous cell carcinoma Journal of Pathology 2002 198 3 335 342 (Pubitemid 35277384)
158. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S. M., Riggins G. J., Willson J. K. V., Markowitz S., Kinzler K. W., Vogelstein B., Velculescu V. E., High frequency of mutations of the PIK3CA gene in human cancers Science 2004 304 5670 554 (Pubitemid 38541907)
159. Shayesteh L., Lu Y., Kuo W. L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G. B., Gray J. W., PlK3CA is implicated as an oncogene in ovarian cancer Nature Genetics 1999 21 1 99 102 (Pubitemid 29036292)
160. Ma Y. Y., Wei S. J., Lin Y. C., Lung J. C., Chang T. C., Whang-Peng J., Liu J. M., Yang D. M., Yang W. K., Shen C. Y., PIK3CA as an oncogene in cervical cancer Oncogene 2000 19 23 2739 2744 (Pubitemid 30339223)
161. Byun D. S., Cho K., Ryu B. K., Lee M. G., Park J. I., Chae K. S., Kim H. J., Chi S. G., Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma International Journal of Cancer 2003 104 3 318 327 (Pubitemid 36249814)
162. Knobbe C. B., Reifenberger G., Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′ kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas Brain Pathology 2003 13 4 507 518 (Pubitemid 37420695)
163. Giannini G., Ristori E., Cerignoli F., Rinaldi C., Zani M., Viel A., Ottini L., Crescenzi M., Martinotti S., Bignami M., Frati L., Screpanti I., Gulino A., Human MRE11 is inactivated in mismatch repair-deficient cancers EMBO Reports 2002 3 3 248 254 (Pubitemid 34269518)
164. Wong A. K. C., Ormonde P. A., Pero R., Chen Y., Lian L., Salada G., Berry S., Lawrence Q., Dayananth P., Ha P., Tavtigian S. V., Teng D. H. F., Bartel P. L., Characterization of a carboxy-terminal BRCA1 interacting protein Oncogene 1998 17 18 2279 2285 (Pubitemid 28515380)
165. Hoeijmakers J. H. J., DNA damage, aging, and cancer New England Journal of Medicine 2009 361 15 1475 1485
166. Helleday T., Petermann E., Lundin C., Hodgson B., Sharma R. A., DNA repair pathways as targets for cancer therapy Nature Reviews Cancer 2008 8 3 193 204 (Pubitemid 351301852)
167. Gupta A. K., Bakanauskas V. J., Cerniglia G. J., Cheng Y., Bernhard E. J., Muschel R. J., McKenna W. G., The Ras radiation resistance pathway Cancer Research 2001 61 10 4278 4282 (Pubitemid 32721000)
168. Grana T. M., Rusyn E. V., Zhou H., Sartor C. I., Cox A. D., Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways Cancer Research 2002 62 14 4142 4150 (Pubitemid 34791086)
169. Edwards E., Geng L., Tan J., Onishko H., Donnelly E., Hallahan D. E., Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation Cancer Research 2002 62 16 4671 4677
170. Gottschalk A. R., Doan A., Nakamura J. L., Stokoe D., Haas-Kogan D. A., Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism International Journal of Radiation Oncology Biology Physics 2005 63 4 1221 1227 (Pubitemid 41505303)
171. Gupta A. K., Cerniglia G. J., Mick R., Ahmed M. S., Bakanauskas V. J., Muschel R. J., McKenna W. G., Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002 International Journal of Radiation Oncology Biology Physics 2003 56 3 846 853 (Pubitemid 36677381)
172. Gupta A. K., McKenna W. G., Weber C. N., Feldman M. D., Goldsmith J. D., Mick R., Machtay M., Rosenthal D. I., Bakanauskas V. J., Cerniglia G. J., Bernhard E. J., Weber R. S., Muschel R. J., Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction Clinical Cancer Research 2002 8 3 885 892 (Pubitemid 34742122)
173. Kim I. A., Bae S. S., Fernandes A., Wu J., Muschel R. J., McKenna W. G., Birnbaum M. J., Bernhard E. J., Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines Cancer Research 2005 65 17 7902 7910 (Pubitemid 41297268)
174. Lee C. M., Fuhrman C. B., Planelles V., Peltier M. R., Gaffney D. K., Soisson A. P., Dodson M. K., Tolley H. D., Green C. L., Zempolich K. A., Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines Clinical Cancer Research 2006 12 1 250 256 (Pubitemid 43166201)
175. Li B., Yuan M., Kim I. A., Chang C. M., Bernhard E. J., Shu H. K. G., Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin Oncogene 2004 23 26 4594 4602 (Pubitemid 38850407)
176. Clark A. S., West K., Streicher S., Dennis P. A., Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells Molecular cancer therapeutics 2002 1 9 707 717
177. Wallin J. J., Guan J., Prior W. W., Edgar K. A., Kassees R., Sampath D., Belvin M., Friedman L. S., Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer Science Translational Medicine 2010 2 48
178. Tang J. M., He Q. Y., Guo R. X., Chang X. J., Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 2006 51 2 181 191
179. Pal S. K., Reckamp K., Yu H., Figlin R. A., Akt inhibitors in clinical development for the treatment of cancer Expert Opinion on Investigational Drugs 2010 19 11 1355 1366
180. LoPiccolo J., Granville C. A., Gills J. J., Dennis P. A., Targeting Akt in cancer therapy Anti-Cancer Drugs 2007 18 8 861 874 (Pubitemid 47220704)
181. Lindsley C. W., The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update Current Topics in Medicinal Chemistry 2010 10 4 458 477
182. Kondapaka S. B., Singh S. S., Dasmahapatra G. P., Sausville E. A., Roy K. K., Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation Molecular Cancer Therapeutics 2003 2 11 1093 1103
183. van Ummersen L., Binger K., Volkman J., Marnocha R., Tutsch K., Kolesar J., Arzoomanian R., Alberti D., Wilding G., A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer Clinical Cancer Research 2004 10 22 7450 7456 (Pubitemid 39557506)
184. Komai N., Morita Y., Sakuta T., Kuwabara A., Kashihara N., Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis Modern Rheumatology 2007 17 5 385 390 (Pubitemid 47593486)
185. Barnett S. F., Bilodeau M. T., Lindsley C. W., The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation Current Topics in Medicinal Chemistry 2005 5 2 109 125 (Pubitemid 40514509)
186. Lindsley C. W., Barnett S. F., Yaroschak M., Bilodeau M. T., Layton M. E., Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors Current Topics in Medicinal Chemistry 2007 7 14 1349 1363 (Pubitemid 47484764)
187. Hirai H., Sootome H., Nakatsuru Y., Miyama K., Taguchi S., Tsujioka K., Ueno Y., Hatch H., Majumder P. K., Pan B. S., Kotani H., MK-2206, an allosteric akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo Molecular Cancer Therapeutics 2010 9 7 1956 1967
188. Yap T. A., First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors Journal of Clinical Oncology 2011 29 35 4688 4695
189. Markman B., Dienstmann R., Tabernero J., Targeting the PI3K/Akt/mTOR pathwaybeyond rapalogs Oncotarget 2010 1 7 530 543
190. NCT00460278, A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer. US National Institute of Health, Bethesda, Md, USA, 2009, http://clinicaltrials.gov/ct2/show/NCT01028495
191. Wu P., Hu Y. Z., PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress Current Medicinal Chemistry 2010 17 35 4326 4341